As of 2025-05-16, the EV/EBITDA ratio of OptiBiotix Health PLC (OPTI.L) is -11.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPTI.L's latest enterprise value is 17.59 mil GBP. OPTI.L's TTM EBITDA according to its financial statements is -1.56 mil GBP. Dividing these 2 quantities gives us the above OPTI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 12.8x | 8.9x |
| Forward P/E multiples | 10.4x - 14.8x | 12.1x |
| Fair Price | (14.74) - (18.42) | (14.86) |
| Upside | -179.7% - -199.6% | -180.3% |
| Date | EV/EBITDA |
| 2025-05-14 | -11.25 |
| 2025-05-13 | -10.93 |
| 2025-05-12 | -11.25 |
| 2025-05-09 | -11.25 |
| 2025-05-08 | -11.74 |
| 2025-05-07 | -11.74 |
| 2025-05-06 | -12.56 |
| 2025-05-02 | -12.23 |
| 2025-05-01 | -10.93 |
| 2025-04-30 | -11.25 |
| 2025-04-29 | -11.42 |
| 2025-04-28 | -11.42 |
| 2025-04-25 | -11.25 |
| 2025-04-24 | -11.09 |
| 2025-04-23 | -11.74 |
| 2025-04-22 | -11.74 |
| 2025-04-17 | -11.25 |
| 2025-04-16 | -10.93 |
| 2025-04-15 | -10.60 |
| 2025-04-14 | -9.62 |
| 2025-04-11 | -9.62 |
| 2025-04-10 | -9.79 |
| 2025-04-09 | -9.30 |
| 2025-04-08 | -9.79 |
| 2025-04-07 | -9.17 |
| 2025-04-04 | -9.14 |
| 2025-04-03 | -8.65 |
| 2025-04-02 | -9.14 |
| 2025-04-01 | -9.14 |
| 2025-03-31 | -9.14 |
| 2025-03-28 | -9.95 |
| 2025-03-27 | -9.95 |
| 2025-03-26 | -9.95 |
| 2025-03-25 | -10.28 |
| 2025-03-24 | -10.77 |
| 2025-03-21 | -11.09 |
| 2025-03-20 | -11.09 |
| 2025-03-19 | -11.91 |
| 2025-03-18 | -11.42 |
| 2025-03-17 | -10.44 |
| 2025-03-14 | -10.44 |
| 2025-03-13 | -10.44 |
| 2025-03-12 | -10.44 |
| 2025-03-11 | -10.44 |
| 2025-03-10 | -10.93 |
| 2025-03-07 | -11.25 |
| 2025-03-06 | -11.25 |
| 2025-03-05 | -11.25 |
| 2025-03-04 | -11.25 |
| 2025-03-03 | -11.25 |